News

Roche to investigate whether new drug can delay or prevent Alzheimer’s disease
(Reuters) -Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer ...
Roche to test if new drug can prevent Alzheimer’s disease, Bloomberg News reports
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Lenacapavir: After FDA approval, HIV pre-exposure prophylaxis injectable moving closer to EU approval
EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.
Pharmabiz1h
EMA committee recommends approval of Eli Lilly’s donanemab in early symptomatic Alzheimer's disease
EMA committee recommends approval of Eli Lilly’s donanemab in early symptomatic Alzheimer's disease: Indianapolis Monday, July 28, 2025, 13:00 Hrs [IST] Eli Lilly and Company an ...
Free Malaysia Today on MSN9h
Roche to study if new drug can delay or prevent Alzheimer’s
The trial drug Trontinemab is designed to bypass the blood brain barrier, delivering more treatment directly to the brain.
GEN - Genetic Engineering and Biotechnology News20h
FDA Probes Death of Brazilian Boy Linked to Sarepta’s Elevidys
The FDA is investigating the death last month of an eight-year-old boy in Brazil who had received Sarepta Therapeutics’ Elevidys® (delandistrogene moxeparvovec-rokl)—though the company and its ...
Iraqi News12h
France’s Sanofi helps Iraq develop pharmaceutical industry
Baghdad (IraqiNews.com) – The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French ...